{
    "title": "[ACC] Should Gene Editing Technologies Be Used In Humans?",
    "date": "December 18, 2019",
    "links": [
        "https://slatestarcodex.com/2019/12/09/2019-adversarial-collaboration-entries/",
        "https://www.technologyreview.com/s/612458/exclusive-chinese-scientists-are-creating-crispr-babies/",
        "https://www.nature.com/articles/d41586-019-01580-1",
        "https://www.npr.org/sections/health-shots/2019/08/22/746321083/scientists-attempt-controversial-experiment-to-edit-dna-in-human-sperm-using-cri",
        "https://www.ncbi.nlm.nih.gov/pubmed/28123068",
        "https://www.broadinstitute.org/what-broad/areas-focus/project-spotlight/questions-and-answers-about-crispr",
        "https://www.ncbi.nlm.nih.gov/pubmed/22745249",
        "https://www.ncbi.nlm.nih.gov/books/NBK21894/",
        "http://www.npr.org/blogs/health/2015/03/20/394311141/scientists-urge-temporary-moratorium-on-human-genome-edits",
        "https://www.nature.com/articles/35038533",
        "https://www.ncbi.nlm.nih.gov/pubmed/10784449?dopt=Abstract",
        "https://www.sciencedaily.com/releases/2008/08/080807175438.htm",
        "https://en.wikipedia.org/wiki/Oncogene",
        "https://www.khanacademy.org/science/biology/classical-genetics/chromosomal-basis-of-genetics/a/linkage-mapping",
        "https://www.nature.com/articles/s41591-018-0049-z",
        "https://www.nature.com/articles/s41591-018-0050-6",
        "https://www.ncbi.nlm.nih.gov/pubmed/1614522",
        "https://www.sciencenews.org/article/crispr-gene-editor-first-human-clinical-trials",
        "https://www.ncbi.nlm.nih.gov/pubmed/22251007",
        "https://med.stanford.edu/news/all-news/2019/04/scientists-use-crispr-for-possible-bubble-boy-therapy.html",
        "https://www.nature.com/articles/s41467-019-09614-y",
        "https://med.stanford.edu/news/all-news/2019/04/scientists-use-crispr-for-possible-bubble-boy-therapy.html",
        "http://www.acrackincreation.com/",
        "https://science.sciencemag.org/content/331/6019/872.3",
        "https://www.ncbi.nlm.nih.gov/pubmed/10791557",
        "https://www.medscape.com/answers/205926-15310/what-is-the-prevalence-of-sickle-cell-disease-scd-in-the-us",
        "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123269/",
        "https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(19)30169-3/fulltext",
        "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3708540/",
        "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481955/",
        "https://science.sciencemag.org/content/331/6019/872.3",
        "https://www.ncbi.nlm.nih.gov/pubmed/29727686",
        "https://www.alzheimers.org.uk/about-dementia/risk-factors-and-prevention/alzheimers-disease-and-genes",
        "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1683508/pdf/ajhg00107-0104.pdf",
        "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931830/",
        "https://www.nature.com/articles/pr2005134",
        "https://www.ncbi.nlm.nih.gov/pubmed/15817501",
        "https://www.cell.com/ajhg/fulltext/S0002-9297(12)00538-1",
        "https://www.internationalgenome.org/",
        "https://www.ncbi.nlm.nih.gov/pubmed/22344438",
        "https://www.npr.org/sections/health-shots/2012/12/06/166648187/perfection-is-skin-deep-everyone-has-flawed-genes",
        "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3740116/",
        "https://cebp.aacrjournals.org/content/14/8/1847.long",
        "https://academic.oup.com/ije/article/41/1/24/650703",
        "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841510/",
        "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4254430/",
        "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3384703/",
        "https://www.ncbi.nlm.nih.gov/pubmed/15710962",
        "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3384703/",
        "https://ghr.nlm.nih.gov/primer/howgeneswork/epigenome",
        "https://www.ncbi.nlm.nih.gov/pubmed/17522677",
        "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798916/",
        "https://academic.oup.com/toxsci/article/100/1/7/1622402",
        "https://www.ncbi.nlm.nih.gov/pubmed/17369845",
        "https://www.icr.ac.uk/our-research/centres-and-collaborations/centres-at-the-icr/centre-for-evolution-and-cancer/the-darwin-cancer-blog/page-details/when-normal-is-the-favoured-type",
        "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3569482/",
        "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5075244/",
        "https://www.ncbi.nlm.nih.gov/pubmed/29039115",
        "https://www.sciencedaily.com/releases/2008/08/080807175438.htm",
        "https://my.clevelandclinic.org/health/diseases/10255-graft-vs-host-disease-an-overview-in-bone-marrow-transplant",
        "https://www.ncbi.nlm.nih.gov/pubmed/28123068",
        "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5113113/",
        "https://www.synthego.com/blog/car-t-crispr-cancer",
        "https://www.hiv.gov/hiv-basics/overview/data-and-trends/global-statistics",
        "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3344725/",
        "https://en.wikipedia.org/wiki/Sperm_washing",
        "https://apnews.com/4997bb7aa36c45449b488e19ac83e86d",
        "https://edition.cnn.com/2018/11/29/health/china-gene-editing-he-jiankui-intl/index.html",
        "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4779710/",
        "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5213777/",
        "https://www.ncbi.nlm.nih.gov/pubmed/9466996",
        "https://wwwnc.cdc.gov/eid/article/16/10/10-0108_article",
        "https://www.nap.edu/catalog/24623/human-genome-editing-science-ethics-and-governance",
        "https://www.nap.edu/catalog/24623/human-genome-editing-science-ethics-and-governance",
        "https://jmg.bmj.com/content/41/2/e13",
        "https://wwwnc.cdc.gov/eid/article/16/10/10-0108_article",
        "https://www.nature.com/articles/s41417-018-0016-3",
        "http://www.acrackincreation.com/",
        "https://www.nature.com/articles/s41587-019-0235-7",
        "https://www.nap.edu/catalog/24623/human-genome-editing-science-ethics-and-governance"
    ],
    "url": "https://slatestarcodex.com/2019/12/18/acc-should-gene-editing-technologies-be-used-in-humans/",
    "summary": "Key ideas:\n- CRISPR technology allows for genetic modifications in human embryos, potentially curing certain diseases and conferring resistance to others\n- However, the long-term consequences of germline modification raise ethical concerns, especially if unintended changes are introduced\n- A balance between genetic fitness and diversity exists, and some genetic variants that may appear deleterious actually offer selective advantages\n- There are limitations to our understanding of gene-disease links, and genetic mutations do not always directly lead to disease\n- Exposome accounts for factors like lifestyle, socioeconomic status, etc. besides genetics for disease manifestation\n- Gene expression is responsible for driving human health than the genes themselves\n- Cancer treatment has not seen significant improvement in decades, thus new techniques like CRISPR are being tested to treat cancer\n- Off-the-shelf CAR T cells utilize gene editing to prevent rejection by host immune system and GvHD\n- Gene editing using CRISPR technology was used to edit the CCR5 gene in human embryos to provide immunity for HIV, the decision had numerous ethical implications\n- Distinction between somatic and germline genome modifications is made, germline edits can be passed down over generations\n- Gene editing can offer potential treatments for genetic diseases.\n- There are risks and limitations to gene editing technology.\n- Germline editing may be necessary for some genetic diseases, but it is more controversial than somatic cell editing.\n- Misuse is a potential concern for gene editing, but continued research is necessary to ensure patient safety.\n\nKey learnings:\n- CRISPR technology is being used in clinical trials for cancers and blood disorders, but the safety and efficacy of gene editing remain a concern\n- Germline modifications may have long-term consequences that could inadvertently introduce new diseases, and precise editing requires a better understanding of the human genome and gene-disease associations\n- Genetic mutations that may appear harmful offer selective advantages, and a better understanding of natural selection is necessary for evaluating how to apply genetic modifications\n- Overall, genetics is not the sole determinant of disease expression, and environmental factors like diet and lifestyle play significant roles\n- Genetic predisposition and gene expression both contribute to disease manifestation\n- Gene editing with CRISPR has shown promise in cancer therapy and HIV prevention\n- The distinction between disease prevention and enhancement is not clear-cut, blurring ethical boundaries\n- There are trade-offs to consider when using gene editing technology.\n- Germline editing has potential benefits, but also poses risks.\n- Gene editing guidelines should incorporate input from various sources to prevent misuse.\n\nKey questions:\n- What are the long-term consequences of germline modifications, and how can we mitigate risks associated with unintended changes?\n- How can we balance the selective advantages of some genetic variants with the potential risks of introducing new mutations?\n- What are the limitations of our understanding of gene-disease links, and how can we develop a more comprehensive picture of normal phenotypic variation?\n- Ultimately, how can we optimize genomic research and genetic modifications to promote health and wellness for everyone?\n- How exactly is the exposome related to disease manifestation and its risk?\n- How can we utilize gene expression to prevent disease manifestation?\n- What ethical and safety considerations come with the usage of gene editing with CRISPR in human embryos?\n- How does gene editing influence the distinction between somatic and germline genome modifications?\n- How should society move forward with gene editing technology?\n- What are the risks and limitations of gene editing?\n- What is the potential for germline vs. somatic cell editing?\n- How can misuse of gene editing be prevented?\n"
}